Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

WCN24-1263 SYMPTOM IMPROVEMENT ENABLED BY THERANOVA DIALYZER IN HEMODIALYSIS PATIENTS: A BEFORE AND AFTER STUDY.

View resource
HDx

Immunomodulation Driven by Theranova Filter during a Single HD Session.

View resource
HDx

WCN24-1658 Effectiveness of Medium Cut-Off Dialyzers in Hemodialysis Patients: An Economic Analysis.

View resource
HDx

Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity.

View resource
HDx

Theranova versus FX80: The impact on anemia management in hemodialysis.

View resource
HDx

Effect of Hemodialysis with Medium Cut-Off versus High-Flux Membranes on Endothelial Function of Patients with Chronic Kidney Disease

View resource
HDx

Latest Trends in Hemodiafiltration.

View resource
HDx

Most recently developed polyester polymer alloy dialyzer: A new medium cut-off membrane?.

View resource
HDx

Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring.

View resource
HDx

Intradialytic Tolerance and Recovery Time in Different High-Efficiency Hemodialysis Modalities.

View resource
HDx

The Budgetary Impact of Introducing HDx therapy enabled by Theranove Dialyzer compared to High Flux Hemodialysis in private sector in the Kingdom of Saudia Arabia

View resource
HDx

Endotoxin Retentive Performance of the Fresenius FX CorAL Dialyzer.

View resource